- Home
- MOGU vs QNCX Comparison
MOGU vs QNCX Comparison
Compare MOGU & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOGU | QNCX |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.8M | 19.9M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MOGU | QNCX |
|---|---|---|
| Price | $2.15 | $1.08 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.8K | ★ 1.5M |
| Earning Date | 01-29-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.88 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.81 | ★ $0.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.83 | $0.08 |
| 52 Week High | $8.10 | $4.55 |
Technical Indicators
Market Signals| Indicator | MOGU | QNCX |
|---|---|---|
| Relative Strength Index (RSI) | 40.71 | 49.56 |
| Support Level | $2.02 | $0.10 |
| Resistance Level | $2.57 | $1.50 |
| Average True Range (ATR) | 0.19 | 0.11 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 0.00 | 50.89 |
Price Performance
Historical ComparisonAbout MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.